About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 843748, 8 pages
http://dx.doi.org/10.1155/2013/843748
Research Article

Comparative Analyses of the β-Tubulin Gene and Molecular Modeling Reveal Molecular Insight into the Colchicine Resistance in Kinetoplastids Organisms

1Laboratorio de Bioquímica y Biología Molecular de Parásitos, Instituto de Biología Experimental (IBE), Facultad de Ciencias, Universidad Central de Venezuela (UCV), Caracas 1041A, Venezuela
2Unidad de Química Medicinal, Facultad de Farmacia, Universidad Central de Venezuela, Caracas 1041A, Venezuela
3Laboratorio de Inmunoparasitología, Centro de Microbiología, Instituto Venezolano de Investigaciones Científicas (IVIC), Caracas 1020A, Venezuela

Received 29 April 2013; Accepted 16 July 2013

Academic Editor: Georgios Theodoropoulos

Copyright © 2013 Luis Luis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “Control of the leishmaniasis,” WHO Technical Report Series, WHO, Geneva, Switzerland, 2010.
  2. A. Mendoza-León, J. J. Shaw, and F. J. Tapia, “A guide for the cutaneous leishmaniasis connoisseur,” in Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis, F. J. Tapia, G. Cáceres-Dittmar, and M. A. Sánchez, Eds., pp. 1–23, R.G. Landes Company Biomedical Publishers, Austin, Tex, USA, 1996.
  3. S. L. Croft, S. Sundar, and A. H. Fairlamb, “Drug resistance in leishmaniasis,” Clinical Microbiology Reviews, vol. 19, no. 1, pp. 111–126, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Sundar, F. Rosenkaimer, M. K. Makharia et al., “Trial of oral miltefosine for visceral leishmaniasis,” The Lancet, vol. 352, no. 9143, pp. 1821–1823, 1998. View at Scopus
  5. X. Serrano-Martín, G. Payares, M. De Lucca, J. C. Martinez, A. Mendoza-León, and G. Benaim, “Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 12, pp. 5108–5113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Kavallaris, “Microtubules and resistance to tubulin-binding agents,” Nature Reviews Cancer, vol. 10, no. 3, pp. 194–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. B. J. Fennell, J. A. Naughton, J. Barlow et al., “Microtubules as antiparasitic drug targets,” Expert Opinion on Drug Discovery, vol. 3, no. 5, pp. 501–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. P. Jackson, S. Vaughan, and K. Gull, “Comparative genomics and concerted evolution of β-tubulin paralogs in Leishmania spp,” BMC Genomics, vol. 7, p. 137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Luis, A. Ramírez, C. M. Aguilar, S. Eresh, D. C. Barker, and A. Mendoza-León, “The genomic fingerprinting of the coding region of the β-tubulin gene in Leishmania identification,” Acta Tropica, vol. 69, no. 3, pp. 193–204, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Mendoza-León and D. C. Barker, “Variation of a multigene family in New World Leishmania: the β-tubulin gene region,” in Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis, F. J. Tapia, G. Cáceres-Dittmar, and M. A. Sánchez, Eds., pp. 107–128, R.G. Landes Company Biomedical Publishers, Austin, Tex, USA, 1996.
  11. A. Mendoza-León, L. Luis, and C. Martinez, “The β-tubulin gene region as a molecular marker to distinguish Leishmania parasites,” in Methods in Molecular Biology. Gene Probes Principles and Protocols, M. Aquino de Muro and R. Rapley, Eds., vol. 179, pp. 61–83, Humana Press, Totowa, NJ, USA, 2002.
  12. C. Délye, Y. Menchari, S. Michel, and H. Darmency, “Molecular bases for sensitivity to tubulin-binding herbicides in green foxtail,” Plant Physiology, vol. 136, no. 4, pp. 3920–3932, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. A. Werbovetz, D. L. Sackett, D. Delfín et al., “Selective antimicrotubule activity of N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5) against kinetoplastid parasites,” Molecular Pharmacology, vol. 64, no. 6, pp. 1325–1333, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. K. A. Werbovetz, J. J. Brendle, and D. L. Sackett, “Purification, characterization, and drug susceptibility of tubulin from Leishmania,” Molecular and Biochemical Parasitology, vol. 98, no. 1, pp. 53–65, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. K. A. Werbovetz and R. E. Morgan, “Selective lead compounds against kinetoplastid tubulin,” Advances in Experimental Medicine and Biology, vol. 625, pp. 33–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. T. H. Macrae and K. Gull, “Purification and assembly in vitro of tubulin from Trypanosoma brucei brucei,” Biochemical Journal, vol. 265, no. 1, pp. 87–93, 1990. View at Scopus
  17. A. J. Yakovich, F. L. Ragone, J. D. Alfonzo, D. L. Sackett, and K. A. Werbovetz, “Leishmania tarentolae: purification and characterization of tubulin and its suitability for antileishmanial drug screening,” Experimental Parasitology, vol. 114, no. 4, pp. 289–296, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Gull, “The cytoskeleton of trypanosomatid parasites,” Annual Review of Microbiology, vol. 53, pp. 629–655, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Bai, D. G. Covell, X. Pei et al., “Mapping the binding site of colchicinoids on β-tubulin: 2-chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354,” Journal of Biological Chemistry, vol. 275, no. 51, pp. 40443–40452, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Uppuluri, L. Knipling, D. L. Sackett, and J. Wolff, “Localization of the colchicine-binding site of tubulin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 24, pp. 11598–11602, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. K. H. Downing, “Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics,” Annual Review of Cell and Developmental Biology, vol. 16, pp. 89–111, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Nogales, S. G. Wolf, and K. H. Downing, “Structure of the αβ tubulin dimer by electron crystallography,” Nature, vol. 391, no. 6663, pp. 199–203, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. R. B. G. Ravelli, B. Gigant, P. A. Curmi et al., “Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain,” Nature, vol. 428, no. 6979, pp. 198–202, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Mendoza-Leon, J. C. Havercroft, and D. C. Barker, “The RFLP analysis of the β-tubulin gene region in New World Leishmania,” Parasitology, vol. 111, no. 1, pp. 1–9, 1995. View at Scopus
  25. P. C. Ng and S. Henikoff, “SIFT: predicting amino acid changes that affect protein function,” Nucleic Acids Research, vol. 31, no. 13, pp. 3812–3814, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. P. C. Ng and S. Henikoff, “Predicting the effects of amino acid substitutions on protein function,” Annual Review of Genomics and Human Genetics, vol. 7, pp. 61–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Xi, I. M. Jones, and H. W. Mohrenweiser, “Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function,” Genomics, vol. 83, no. 6, pp. 970–979, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Gigant, C. Wang, R. B. G. Ravelli et al., “Structural basis for the regulation of tubulin by vinblastine,” Nature, vol. 435, no. 7041, pp. 519–522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Schwede, J. Kopp, N. Guex, and M. C. Peitsch, “SWISS-MODEL: an automated protein homology-modeling server,” Nucleic Acids Research, vol. 31, no. 13, pp. 3381–3385, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Guex and M. C. Peitsch, “SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling,” Electrophoresis, vol. 18, no. 15, pp. 2714–2723, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. J. C. Phillips, R. Braun, W. Wang et al., “Scalable molecular dynamics with NAMD,” Journal of Computational Chemistry, vol. 26, no. 16, pp. 1781–1802, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Pedretti, L. Villa, and G. Vistoli, “VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming,” Journal of Computer-Aided Molecular Design, vol. 18, no. 3, pp. 167–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Wiederstein and M. J. Sippl, “ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins,” Nucleic acids research, vol. 35, pp. W407–W410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. R. A. Laskowski, M. W. MacArthur, D. S. Moss, and J. M. Thornton, “PROCHECK-a program to check the stereochemical quality of protein structures,” Journal of Applied Crystallography, vol. 26, pp. 283–291, 1993. View at Publisher · View at Google Scholar
  35. S.-Q. Li, M.-C. Fung, S. A. Reid, N. Inoue, and Z.-R. Lun, “Immunization with recombinant β-tubulin from Trypanosoma evansi induced protection against T. evansi, T. equiperdum and T. b. brucei infection in mice,” Parasite Immunology, vol. 29, no. 4, pp. 191–199, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Massarotti, A. Coluccia, R. Silvestri, G. Sorba, and A. Brancale, “The tubulin colchicine domain: a molecular modeling perspective,” ChemMedChem, vol. 7, no. 1, pp. 33–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. F. L. Henriquez, P. R. Ingram, S. P. Muench, D. W. Rice, and C. W. Roberts, “Molecular basis for resistance of Acanthamoeba tubulins to all major classes of antitubulin compounds,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 3, pp. 1133–1135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Lu, J. Chen, M. Xiao, W. Li, and D. D. Miller, “An overview of tubulin inhibitors that interact with the colchicine binding site,” Pharmaceutical Research, vol. 29, no. 11, pp. 2943–2971, 2012. View at Publisher · View at Google Scholar
  39. K. Chen, J. T. Huzil, H. Freedman et al., “Identification of tubulin drug binding sites and prediction of relative differences in binding affinities to tubulin isotypes using digital signal processing,” Journal of Molecular Graphics and Modelling, vol. 27, no. 4, pp. 497–505, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. C. H. A. Cheung, S.-Y. Wu, T.-R. Lee et al., “Cancer cells acquire mitotic drug resistance properties through β I-tubulin mutations and alterations in the expression of β-tubulin isotypes,” PloS one, vol. 5, no. 9, p. e12564, 2010. View at Scopus
  41. C. Stengel, S. P. Newman, M. P. Leese, B. V. L. Potter, M. J. Reed, and A. Purohit, “Class III Β-tubulin expression and in vitro resistance to microtubule targeting agents,” British Journal of Cancer, vol. 102, no. 2, pp. 316–324, 2010. View at Publisher · View at Google Scholar · View at Scopus